vTv Therapeutics Inc logo

vTv Therapeutics Inc - Class A

NEW
NAS:VTVT (USA)   Class A
$ 16.97 +0.78 (+4.82%) 02:26 PM EST
At Loss
P/B:
3.63
Market Cap:
$ 44.33M
Enterprise V:
$ 7.82M
Volume:
16.71K
Avg Vol (2M):
29.04K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
16.71K
At Loss
Avg Vol (2M):
29.04K

Business Description

vTv Therapeutics Inc logo
vTv Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US9183851057

Share Class Description:

VTVT: Class A
Description
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Name Current Vs Industry Vs History
Cash-To-Debt 217.43
Equity-to-Asset 0.32
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.7
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.34
Quick Ratio 7.34
Cash Ratio 7.07
Days Sales Outstanding 121.52

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16
Shareholder Yield % -114.1

Financials (Next Earnings Date:2025-05-09 Est.)

VTVT's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VTVT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

vTv Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.017
EPS (TTM) ($) -3.41
Beta 0.51
3-Year Sharpe Ratio 0.11
3-Year Sortino Ratio 0.23
Volatility % 66.85
14-Day RSI 46.24
14-Day ATR ($) 2.12551
20-Day SMA ($) 17.507275
12-1 Month Momentum % -30.34
52-Week Range ($) 12.1201 - 29.85
Shares Outstanding (Mil) 2.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

vTv Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

vTv Therapeutics Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

vTv Therapeutics Inc Frequently Asked Questions

What is vTv Therapeutics Inc(VTVT)'s stock price today?
The current price of VTVT is $16.97. The 52 week high of VTVT is $29.85 and 52 week low is $12.12.
When is next earnings date of vTv Therapeutics Inc(VTVT)?
The next earnings date of vTv Therapeutics Inc(VTVT) is 2025-05-09 Est..
Does vTv Therapeutics Inc(VTVT) pay dividends? If so, how much?
vTv Therapeutics Inc(VTVT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1